Alzheimer’s imaging and clinical trials

More than 400 clinical trials are presently looking at new treatments for Alzheimer’s disease (AD) and many of them are actively recruiting. Many of the researches are based on decreasing the toxic effects of amyloid-beta in the brain, targeting amyloid production, blocking the accumulation of amyloid-beta into plaques, Aiming at Tau, Improving Cognition with Serotonin and Dietary Supplements.

    Related Conference of Alzheimer’s imaging and clinical trials

    Alzheimer’s imaging and clinical trials Conference Speakers